Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research Grade Anti-Human CD274/PD-L1/B7-H1 Antibody (BMS-936559/MDX-1105) | Login | Research Grade Anti-Human CD274/PD-L1/B7-H1 Antibody (BMS-936559/MDX-1105) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Belimumab | Login | Research Grade Belimumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Atezolizumab | Login | Research Grade Atezolizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Durvalumab | Login | Research Grade Durvalumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human HLA-DR10 Antibody (Oncolym) | Login | Research Grade Anti-Human HLA-DR10 Antibody (Oncolym) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Acasunlimab | Login | Research Grade Acasunlimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Erfonrilimab | Login | Research Grade Erfonrilimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Garivulimab | Login | Research Grade Garivulimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Sudubrilimab | Login | Research Grade Sudubrilimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Alomfilimab | Login | Research Grade Alomfilimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Izuralimab | Login | Research Grade Izuralimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Tarlatamab | Login | Research Grade Tarlatamab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Socazolimab | Login | Research Grade Socazolimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Tagitanlimab | Login | Research Grade Tagitanlimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Betifisolimab | Login | Research Grade Betifisolimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Lesabelimab | Login | Research Grade Lesabelimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Reozalimab | Login | Research Grade Reozalimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Crefmirlimab | Login | Research Grade Crefmirlimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human SIGLEC15 Antibody (5G12) | Login | Research Grade Anti-Human SIGLEC15 Antibody (5G12) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD246/ALK (CDX-0125-TEI) | Login | Research Grade Anti-Human CD246/ALK (CDX-0125-TEI) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD246/ALK (DLX521) | Login | Research Grade Anti-Human CD246/ALK (DLX521) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CCR4/CNOT6 (AT007) | Login | Research Grade Anti-Human CCR4/CNOT6 (AT007) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CCR4/CNOT6 (AT008) | Login | Research Grade Anti-Human CCR4/CNOT6 (AT008) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD371/CLEC12A (DCLL9718S) | Login | Research Grade Anti-Human CD371/CLEC12A (DCLL9718S) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Briobacept | Login | Research Grade Briobacept | ||||||||||||||||
|